NB: A safety is a safety issue that could ‘significant issue’ adversely affect the safety of participants or materially impact on the continued ethical acceptability or conduct of the trial. If no, please comment: For mutli-centre NMA clinical trials, have these also been reported to the RGO at the site of occurrence: Yes No If no, please comment: Please attach safety reporting documentation as may be required in accordance with the NHMRC and . ADDITIONAL INFORMATION Please detail any further comments, issues or other information that has not already been covered in your report: On completion of this Report, please submit to with the Subject Header in the following format: HREC reference number, Principal name and current month and year Investigator’s EXAMPLE Email Subject Header: HREC/16/WCHN/222 Bloggs, Jo - August 2018 – Refer to for further information.
NB: A ‘significant safety issue’ is a safety issue that could adversely affect the safety of participants or materially impact on the continued ethical acceptability or conduct of the trial. If no, please comment: For mutli-centre NMA clinical trials, have these also been reported to the RGO at the site of occurrence: Yes No If no, please comment: Please attach safety reporting documentation as may be required in accordance with the NHMRC and . ADDITIONAL INFORMATION Please detail any further comments, issues or other information that has not already been covered in your report: On completion of this Report, please submit to with the Subject Header in the following format: HREC reference number, Principal Investigator’s name and current month and year EXAMPLE Email Subject Header: HREC/16/WCHN/222 – Bloggs, Jo - August 2018 Refer to for further information.
WCHNResearchAnnualReportingFormversionAugust2018FINAL_002.docx